LFA
ABBV icon

LGT Financial Advisors’s AbbVie ABBV Stock Holding History

LGT Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-500
Closed -$67.4K – 929
2023
Q2 		$67.4K Buy
+500
New +$73.3K 0.07% 154

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LGT Financial Advisors's ABBV Position: Q1 2026 in Review

LGT Financial Advisors increased its AbbVie (ABBV) stake by 0.4% in Q1 2026, buying an estimated $1.33K and bringing the position to 1,514 shares worth $329K. The position accounts for 1.69% of the portfolio, ranked #8.

LGT Financial Advisors first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $503K in Q1 2024. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • LGT Financial Advisors held 1,514 shares of AbbVie worth $329K as of Q1 2026.
  • LGT Financial Advisors bought 6 AbbVie shares in Q1 2026, an estimated $1.33K.
  • AbbVie made up 1.69% of LGT Financial Advisors's portfolio in Q1 2026, its #8 holding.
  • LGT Financial Advisors first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
  • LGT Financial Advisors's AbbVie position peaked at $503K in Q1 2024.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on LGT Financial Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.